USPTO serial 79405037
TAVEREN THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 17, 2025
- Examiner
- JANSON, ANDREW KYLE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TAVEREN THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason J. Mazur
Jason J. Mazur ArentFox Schiff LLP1717 K Street, NWWashington, DC 20006-5344United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical drugs for treatment of oncological diseases; chemical preparations for medical purposes for treatment of oncological diseases; diagnostic substances for medical use; chemical preparations for pharmaceutical purposes for treatment of oncological diseases; adjuvants for medical purposes; diagnostic preparations for medical purposes; pharmaceutical compositions for treatment of oncological diseases; biological preparations for use in cell cultures for medical purposes. | ACTIVE | — |
| 042 | Research and development for the pharmaceutical industry; development of pharmaceutical preparations and medicines; medical research in the field of oncology; medical research in the field of neurobiology; chemical analysis; analytical laboratory services, namely, research laboratory analysis services in the field of biochemistry; biochemistry research services; chemistry services, namely, chemical synthesis; advisory services relating to research and development of pharmaceutical drugs; science and technology services, namely, scientific research; technological consultancy in the field of treatment of oncological diseases; scientific laboratory services; conducting early evaluations in the field of new pharmaceuticals. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IOCB Tech s.r.o.
- Other trademarks owned by IOCB Tech s.r.o.
- Other trademarks owned by IOCB Tech s.r.o.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TAVEREN THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 18, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 18, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 17, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 17, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 6, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 6, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 22, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |